{"id":243696,"date":"2026-09-11T12:22:13","date_gmt":"2026-09-11T06:52:13","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=243696"},"modified":"2026-09-11T12:22:13","modified_gmt":"2026-09-11T06:52:13","slug":"pfizer-q2-results-fy27-preview-date-expectations","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/","title":{"rendered":"Pfizer Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Pfizer share price Rs 4,085.20 on 11 September 2026, down 1.00%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 204.00 crore. Q2 FY26 base a profit of Rs 189.00 crore.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">The Pfizer Q2 results date for FY27 is not confirmed, and Pfizer Ltd. had not filed a board meeting intimation with the NSE or BSE as of 11 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 642.00 crore in revenue and a profit of Rs 189.00 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.<\/p>\n<\/p><\/div>\n<p>The Pfizer Q2 results FY27 announcement is the next scheduled earnings event for <a href=\"https:\/\/univest.in\/stocks\/pfizer\/pfizer-ltd-share-price-today\">Pfizer Ltd.<\/a>, the Indian arm of the global pharmaceutical company, selling prescription medicines and vaccines across pain management, anti-infectives, vitamins and specialty care through a nationwide distribution and prescription network. The stock traded at Rs 4,085.20 on the NSE on 11 September 2026, down 1.00% from the previous close of Rs 4,126.50, about 29.0% below its 52-week high of Rs 5,750.00 and 0.1% above its 52-week low of Rs 4,080.00.<\/p>\n<p>What makes the Pfizer Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 642.00 crore of revenue and a profit of Rs 189.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 653.00 crore and a profit of Rs 204.00 crore. Everything below is built from those reported figures rather than from any forecast.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=pfizer_q2_fy27\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#When_Is_the_Pfizer_Q2_Results_FY27_Date\" title=\"When Is the Pfizer Q2 Results FY27 Date?\">When Is the Pfizer Q2 Results FY27 Date?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#Pfizer_Q2_Results_Expectations_What_the_Market_Is_Actually_Tracking\" title=\"Pfizer Q2 Results Expectations: What the Market Is Actually Tracking\">Pfizer Q2 Results Expectations: What the Market Is Actually Tracking<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#Pfizer_Q2_Results_Preview_The_Q1_FY27_Actuals_It_Builds_On\" title=\"Pfizer Q2 Results Preview: The Q1 FY27 Actuals It Builds On\">Pfizer Q2 Results Preview: The Q1 FY27 Actuals It Builds On<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#Q2_FY26_Base_The_Comparison_Pfizer_Q2_Results_FY27_Must_Beat\" title=\"Q2 FY26 Base: The Comparison Pfizer Q2 Results FY27 Must Beat\">Q2 FY26 Base: The Comparison Pfizer Q2 Results FY27 Must Beat<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#Pfizer_Quarterly_Results_Trend_Over_the_Last_Four_Quarters\" title=\"Pfizer Quarterly Results Trend Over the Last Four Quarters\">Pfizer Quarterly Results Trend Over the Last Four Quarters<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#Key_Factors_That_Could_Shape_Pfizer_Q2_Results_FY27\" title=\"Key Factors That Could Shape Pfizer Q2 Results FY27\">Key Factors That Could Shape Pfizer Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#A_Few_Brands_Carry_the_Portfolio\" title=\"A Few Brands Carry the Portfolio\">A Few Brands Carry the Portfolio<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#Other_Income_Is_a_Real_Component\" title=\"Other Income Is a Real Component\">Other Income Is a Real Component<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#The_Share_Price_Has_Fallen_Hard\" title=\"The Share Price Has Fallen Hard\">The Share Price Has Fallen Hard<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#Pfizer_Q2_Results_FY27_Share_Price_and_Valuation_Going_Into_the_Print\" title=\"Pfizer Q2 Results FY27: Share Price and Valuation Going Into the Print\">Pfizer Q2 Results FY27: Share Price and Valuation Going Into the Print<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#What_Investors_Should_Watch_When_Pfizer_Q2_Results_Are_Announced\" title=\"What Investors Should Watch When Pfizer Q2 Results Are Announced\">What Investors Should Watch When Pfizer Q2 Results Are Announced<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#Conclusion_on_Pfizer_Q2_Results_FY27\" title=\"Conclusion on Pfizer Q2 Results FY27\">Conclusion on Pfizer Q2 Results FY27<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#FAQs_on_Pfizer_Q2_Results_FY27\" title=\"FAQs on Pfizer Q2 Results FY27\">FAQs on Pfizer Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#What_is_the_Pfizer_Q2_results_date_for_FY27\" title=\"What is the Pfizer Q2 results date for FY27?\">What is the Pfizer Q2 results date for FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#What_quarter_do_the_Pfizer_Q2_results_2026_cover\" title=\"What quarter do the Pfizer Q2 results 2026 cover?\">What quarter do the Pfizer Q2 results 2026 cover?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#What_were_the_Pfizer_Q1_FY27_results\" title=\"What were the Pfizer Q1 FY27 results?\">What were the Pfizer Q1 FY27 results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#What_were_Pfizer_Q2_FY26_results_in_the_September_2025_quarter\" title=\"What were Pfizer Q2 FY26 results in the September 2025 quarter?\">What were Pfizer Q2 FY26 results in the September 2025 quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#What_are_the_main_Pfizer_Q2_results_expectations_this_quarter\" title=\"What are the main Pfizer Q2 results expectations this quarter?\">What are the main Pfizer Q2 results expectations this quarter?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#What_is_Pfizer_share_price_today_ahead_of_the_Q2_earnings\" title=\"What is Pfizer share price today ahead of the Q2 earnings?\">What is Pfizer share price today ahead of the Q2 earnings?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/pfizer-q2-results-fy27-preview-date-expectations\/#Is_Pfizer_a_good_stock_to_buy_before_the_Q2_results\" title=\"Is Pfizer a good stock to buy before the Q2 results?\">Is Pfizer a good stock to buy before the Q2 results?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"When_Is_the_Pfizer_Q2_Results_FY27_Date\"><\/span><strong>When Is the Pfizer Q2 Results FY27 Date?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Pfizer Q2 results date for FY27 is not confirmed. As of 11 September 2026, Pfizer Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.<\/p>\n<p>What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Pfizer Q2 results date becomes public through that filing rather than through any advance announcement.<\/p>\n<p>The Pfizer Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Pfizer.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pfizer_Q2_Results_Expectations_What_the_Market_Is_Actually_Tracking\"><\/span><strong>Pfizer Q2 Results Expectations: What the Market Is Actually Tracking<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>No verified analyst estimate for the Pfizer Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Pfizer. The Pfizer Q2 results watchlist below is built from what the company has actually reported and disclosed.<\/p>\n<p>The first is revenue, which was Rs 642 crore in September 2025 against Rs 653 crore in Q1 FY27. Sales have been unusually stable, staying inside a Rs 603 crore to Rs 653 crore band across all five quarters and growing 8% year on year.<\/p>\n<p>The second is the operating margin, which was 36% in September 2025 and 38% in Q1 FY27. Margin has improved from 35% a year ago and is the highest of the window, so the September comparison is a favourable one.<\/p>\n<p>The third is the other income line, which was negative Rs 20 crore in December 2025 against positive Rs 42 crore to Rs 67 crore elsewhere. That swing alone cut December net profit to Rs 142 crore from Rs 189 crore while operating profit was almost unchanged.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Pfizer Ltd. Live Fundamentals on the Univest Screener<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pfizer_Q2_Results_Preview_The_Q1_FY27_Actuals_It_Builds_On\"><\/span><strong>Pfizer Q2 Results Preview: The Q1 FY27 Actuals It Builds On<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pfizer Ltd. reported revenue of Rs 653.00 crore in Q1 FY27, up 8.29% from Rs 603.00 crore in Q1 FY26, and a profit of Rs 204.00 crore at the net level, up 6.25% from Rs 192.00 crore in Q1 FY26. These are reported actuals, not estimates.<\/p>\n<p>Sequentially, revenue was up 3.82% over the March 2026 quarter figure of Rs 629.00 crore, and net profit was up 2.00% from Rs 200.00 crore in Q4 FY26. Operating margin stood at 38% in Q1 FY27 against 36% in the September 2025 quarter, which is the comparison the Pfizer Q2 results print will be read against.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Q2_FY26_Base_The_Comparison_Pfizer_Q2_Results_FY27_Must_Beat\"><\/span><strong>Q2 FY26 Base: The Comparison Pfizer Q2 Results FY27 Must Beat<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pfizer Ltd. reported revenue of Rs 642.00 crore and a profit of Rs 189.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Pfizer Q2 results preview.<\/p>\n<p>Net profit in that base quarter was below the Rs 204.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 642.00 crore sits below the Rs 653.00 crore of the June 2026 quarter, which frames how much sequential movement the Pfizer Q2 results print needs to show growth.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pfizer_Quarterly_Results_Trend_Over_the_Last_Four_Quarters\"><\/span><strong>Pfizer Quarterly Results Trend Over the Last Four Quarters<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<thead>\n<tr>\n<th>Quarter<\/th>\n<th>Revenue (Rs Cr)<\/th>\n<th>Net Profit (Rs Cr)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Q2 FY26 (Sep 2025)<\/td>\n<td>642.00<\/td>\n<td>189.00<\/td>\n<\/tr>\n<tr>\n<td>Q3 FY26 (Dec 2025)<\/td>\n<td>645.00<\/td>\n<td>142.00<\/td>\n<\/tr>\n<tr>\n<td>Q4 FY26 (Mar 2026)<\/td>\n<td>629.00<\/td>\n<td>200.00<\/td>\n<\/tr>\n<tr>\n<td>Q1 FY27 (Jun 2026)<\/td>\n<td>653.00<\/td>\n<td>204.00<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company&#8217;s exchange filings, and they are the only basis this Pfizer Q2 results preview uses.<\/p>\n<p>Revenue across those four quarters ranged from Rs 629.00 crore to Rs 653.00 crore, and net profit from Rs 142.00 crore to Rs 204.00 crore. That spread is the honest context for the Pfizer Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Factors_That_Could_Shape_Pfizer_Q2_Results_FY27\"><\/span><strong>Key Factors That Could Shape Pfizer Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Pfizer Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Pfizer has already reported.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"A_Few_Brands_Carry_the_Portfolio\"><\/span><strong>A Few Brands Carry the Portfolio<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A large share of revenue comes from a small set of established prescription brands, so the growth rate depends on prescription volumes and price control decisions on those specific products rather than on a broad pipeline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Other_Income_Is_a_Real_Component\"><\/span><strong>Other Income Is a Real Component<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Excluding the December swing, other income runs Rs 42 crore to Rs 67 crore a quarter, equal to 18% to 32% of operating profit, and comes from a treasury book funded by Rs 4,157 crore of reserves against only Rs 70 crore of borrowings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"The_Share_Price_Has_Fallen_Hard\"><\/span><strong>The Share Price Has Fallen Hard<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The stock trades at Rs 4,085.20 against a 52-week high of Rs 5,750.00, below both its 50-day average of Rs 4,703.05 and its 200-day average of Rs 4,767.07, with a 14-day RSI of 6.54. The effective tax rate was exactly 26% in all five quarters.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Pfizer_Q2_Results_FY27_Share_Price_and_Valuation_Going_Into_the_Print\"><\/span><strong>Pfizer Q2 Results FY27: Share Price and Valuation Going Into the Print<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pfizer share price today is Rs 4,085.20 on the NSE, down Rs 41.30 or 1.00% from the previous close of Rs 4,126.50 on 11 September 2026, ahead of the Pfizer Q2 results announcement.<\/p>\n<table>\n<thead>\n<tr>\n<th>Metric<\/th>\n<th>Value (11 September 2026)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>NSE Symbol<\/td>\n<td>PFIZER<\/td>\n<\/tr>\n<tr>\n<td>Current Market Price<\/td>\n<td>Rs 4,085.20<\/td>\n<\/tr>\n<tr>\n<td>52-Week High<\/td>\n<td>Rs 5,750.00<\/td>\n<\/tr>\n<tr>\n<td>52-Week Low<\/td>\n<td>Rs 4,080.00<\/td>\n<\/tr>\n<tr>\n<td>Market Capitalisation<\/td>\n<td>Rs 18,687 crore<\/td>\n<\/tr>\n<tr>\n<td>PE Ratio<\/td>\n<td>24.33<\/td>\n<\/tr>\n<tr>\n<td>PB Ratio<\/td>\n<td>4.45<\/td>\n<\/tr>\n<tr>\n<td>EPS (TTM)<\/td>\n<td>Rs 167.89<\/td>\n<\/tr>\n<tr>\n<td>Book Value per Share<\/td>\n<td>Rs 919.00<\/td>\n<\/tr>\n<tr>\n<td>Debt to Equity<\/td>\n<td>0.02<\/td>\n<\/tr>\n<tr>\n<td>Return on Equity<\/td>\n<td>18.0%<\/td>\n<\/tr>\n<tr>\n<td>50-Day Moving Average<\/td>\n<td>Rs 4,703.05<\/td>\n<\/tr>\n<tr>\n<td>200-Day Moving Average<\/td>\n<td>Rs 4,767.07<\/td>\n<\/tr>\n<tr>\n<td>RSI (14)<\/td>\n<td>6.54<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The stock trades below both its 50-day average of Rs 4,703.05 and its 200-day average of Rs 4,767.07, with a 14-day RSI of 6.54. None of this is a view on where the shares go once the Pfizer Q2 results are announced, and no price target is offered here.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Pfizer Ltd. live price and quarterly earnings updates.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Investors_Should_Watch_When_Pfizer_Q2_Results_Are_Announced\"><\/span><strong>What Investors Should Watch When Pfizer Q2 Results Are Announced<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Four lines carry most of the information in a company of this size, and reading them in order keeps the Pfizer Q2 results print in proportion.<\/p>\n<ol>\n<li>Revenue against the Rs 642.00 crore reported in the September 2025 base quarter<\/li>\n<li>Net profit against a profit of Rs 189.00 crore in that same quarter<\/li>\n<li>Operating margin against 38% in Q1 FY27<\/li>\n<li>Any exceptional item, provision or one-off gain disclosed alongside the numbers<\/li>\n<\/ol>\n<p>A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Pfizer Q2 results announcement should be read together with the notes to the results rather than the headline alone.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion_on_Pfizer_Q2_Results_FY27\"><\/span><strong>Conclusion on Pfizer Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Pfizer Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Pfizer Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.<\/p>\n<p>On that basis the Pfizer Q2 results FY27 print faces a base of Rs 642.00 crore in revenue and a profit of Rs 189.00 crore, with the most recent quarter having delivered Rs 653.00 crore and a profit of Rs 204.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Pfizer, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Pfizer_Q2_Results_FY27\"><\/span><strong>FAQs on Pfizer Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Pfizer_Q2_results_date_for_FY27\"><\/span><strong>What is the Pfizer Q2 results date for FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Pfizer Q2 results date for FY27 is not confirmed. Pfizer Ltd. had not filed a board meeting intimation with the NSE or BSE as of 11 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_quarter_do_the_Pfizer_Q2_results_2026_cover\"><\/span><strong>What quarter do the Pfizer Q2 results 2026 cover?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Pfizer Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Pfizer Ltd. reports revenue, operating profit and net profit for that period, and the Pfizer Q2 results filing also carries the notes to the accounts.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_the_Pfizer_Q1_FY27_results\"><\/span><strong>What were the Pfizer Q1 FY27 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer Ltd. reported revenue of Rs 653.00 crore in Q1 FY27 and a profit of Rs 204.00 crore at the net level. Revenue was up 8.29% versus Q1 FY26 and net profit was up 6.25% from Rs 192.00 crore in Q1 FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_were_Pfizer_Q2_FY26_results_in_the_September_2025_quarter\"><\/span><strong>What were Pfizer Q2 FY26 results in the September 2025 quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer Ltd. reported revenue of Rs 642.00 crore and a profit of Rs 189.00 crore in Q2 FY26. Operating margin was 36%. Those figures form the base for the Pfizer Q2 results FY27 comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_Pfizer_Q2_results_expectations_this_quarter\"><\/span><strong>What are the main Pfizer Q2 results expectations this quarter?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No verified analyst estimate is publicly available. The Pfizer Q2 results expectations centre on revenue against the Rs 642.00 crore base, net profit against a profit of Rs 189.00 crore, operating margin against 38% in Q1 FY27, and any exceptional item disclosed with the numbers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Pfizer_share_price_today_ahead_of_the_Q2_earnings\"><\/span><strong>What is Pfizer share price today ahead of the Q2 earnings?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Pfizer share price is Rs 4,085.20 on the NSE as of 11 September 2026, down 1.00% from Rs 4,126.50. The stock is about 29.0% below its 52-week high of Rs 5,750.00 and 0.1% above its 52-week low of Rs 4,080.00, at a market capitalisation of Rs 18,687 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Pfizer_a_good_stock_to_buy_before_the_Q2_results\"><\/span><strong>Is Pfizer a good stock to buy before the Q2 results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This article does not offer a buy, sell or hold recommendation on Pfizer Ltd. The stock trades at a price-to-book ratio of 4.45 with a return on equity of 18.0%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is the Pfizer Q2 results date for FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Pfizer Q2 results date for FY27 is not confirmed. Pfizer Ltd. had not filed a board meeting intimation with the NSE or BSE as of 11 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.\"}},{\"@type\":\"Question\",\"name\":\"What quarter do the Pfizer Q2 results 2026 cover?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The Pfizer Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Pfizer Ltd. reports revenue, operating profit and net profit for that period, and the Pfizer Q2 results filing also carries the notes to the accounts.\"}},{\"@type\":\"Question\",\"name\":\"What were the Pfizer Q1 FY27 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pfizer Ltd. reported revenue of Rs 653.00 crore in Q1 FY27 and a profit of Rs 204.00 crore at the net level. Revenue was up 8.29% versus Q1 FY26 and net profit was up 6.25% from Rs 192.00 crore in Q1 FY26.\"}},{\"@type\":\"Question\",\"name\":\"What were Pfizer Q2 FY26 results in the September 2025 quarter?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pfizer Ltd. reported revenue of Rs 642.00 crore and a profit of Rs 189.00 crore in Q2 FY26. Operating margin was 36%. Those figures form the base for the Pfizer Q2 results FY27 comparison.\"}},{\"@type\":\"Question\",\"name\":\"What are the main Pfizer Q2 results expectations this quarter?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No verified analyst estimate is publicly available. The Pfizer Q2 results expectations centre on revenue against the Rs 642.00 crore base, net profit against a profit of Rs 189.00 crore, operating margin against 38% in Q1 FY27, and any exceptional item disclosed with the numbers.\"}},{\"@type\":\"Question\",\"name\":\"What is Pfizer share price today ahead of the Q2 earnings?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pfizer share price is Rs 4,085.20 on the NSE as of 11 September 2026, down 1.00% from Rs 4,126.50. The stock is about 29.0% below its 52-week high of Rs 5,750.00 and 0.1% above its 52-week low of Rs 4,080.00, at a market capitalisation of Rs 18,687 crore.\"}},{\"@type\":\"Question\",\"name\":\"Is Pfizer a good stock to buy before the Q2 results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This article does not offer a buy, sell or hold recommendation on Pfizer Ltd. The stock trades at a price-to-book ratio of 4.45 with a return on equity of 18.0%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer Q2 results FY27 date is not yet confirmed by the exchanges. Here is the September 2026 quarter watchlist for Pfizer Ltd., built on actual Q1 FY27 and Q2 FY26 numbers with no invented estimates.<\/p>\n","protected":false},"author":29,"featured_media":243695,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-243696","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["243695"],"rank_math_title":["Pfizer India Q2 FY27: Date and Expectations"],"rank_math_description":["Pfizer Q2 results FY27 preview: results date status, key expectations, Q1 FY27 and Q2 FY26 actuals, factors to watch and valuation ahead of the September 2026 print."],"rank_math_focus_keyword":["Pfizer Q2 results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/pfizer-q2-results-fy27-preview-date-expectations.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/243696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=243696"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/243696\/revisions"}],"predecessor-version":[{"id":243697,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/243696\/revisions\/243697"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/243695"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=243696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=243696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=243696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}